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        Introduction 
  The skeletal system develops and adapts throughout life in re-
sponse to hormones, cytokines, and external factors such as me-
chanical loading. Maintenance of bone mass in adults is a dynamic 
process that involves a balance of resorption by osteoclasts and 
formation by osteoblasts. For   >  100 yr, it has been known that 
bone is remodeled in accordance with the stresses placed upon it 
(  Frost, 2001  ). Unloading of the skeleton decreases osteogenesis, 
and mechanotransduction is now recognized as one of the major 
factors regulating skeletal mass (  Robling et al., 2006  ). 
  Nucleotides, such as ATP, are thought to be key mediators 
in the response of bone cells to mechanical stimuli (  Dixon and 
Sims, 2000  ;   Robling et al., 2006  ). Many cells release ATP when 
subjected to stretch or fl  uid shear (  Romanello et al., 2001  ; 
  Genetos et al., 2005  ;   Riddle et al., 2007  ). Extracellular ATP can 
then signal through P2 nucleotide receptors present on various 
cell types including osteoblasts. There are two subtypes of P2 
receptors, P2X (ligand-gated cation channels) and P2Y (G protein –
  coupled receptors;   Burnstock, 2007  ). Osteoblasts express mul-
tiple subtypes of P2X and P2Y receptors (  Dixon and Sims, 
2000 ;  Hoebertz et al., 2000 ), but the mechanistic basis of nucleo-
tide effects on bone is not clear. 
  P2X7 receptors function not only as nonselective cation 
channels but can also induce the formation of large membrane 
pores, which allow passage of molecules with size up to 900 kD 
(  North, 2002  ;   Khakh and North, 2006  ). Pore formation may arise 
from dilation of the channel caused by recruitment of additional 
subunits. However, recent evidence supports the possibility that 
P2X7 receptor activation leads to opening of a distinct pore pro-
tein in the plasma membrane (  Pelegrin and Surprenant, 2006  ). 
  P2X7 receptors have been implicated in skeletal re-
modeling and mechanotransduction.   P2rx7 
   /       mice  exhibit 
decreased periosteal bone formation in long bones without a 
difference in length (  Ke et al., 2003  ). Moreover,   P2rx7 
   /       mice 
show reduced osteogenesis in response to mechanical loading 
(  Li et al., 2005  ). We have recently shown that activation of 
P2X7 receptors induces dynamic membrane blebbing in a sub-
population of calvarial cells (  Panupinthu et al., 2007  ). Despite 
these fi  ndings that link P2X7 receptors to anabolic effects on 
  N
ucleotides are released from cells in response to 
mechanical stimuli and signal in an autocrine/
paracrine manner through cell surface P2 recep-
tors.   P2rx7 
    /        mice exhibit diminished appositional 
growth of long bones and impaired responses to mechan-
ical loading. We ﬁ  nd that calvarial sutures are wider in 
  P2rx7 
    /        mice. Functional P2X7 receptors are expressed 
on osteoblasts in situ and in vitro. Activation of P2X7 re-
ceptors by exogenous nucleotides stimulates expression of 
osteoblast markers and enhances mineralization in cul-
tures of rat calvarial cells. Moreover, osteogenesis is sup-
pressed in calvarial cell cultures from   P2rx7 
    /        mice 
compared with the wild type. P2X7 receptors couple to 
production of the potent lipid mediators lysophosphatidic 
acid (LPA) and prostaglandin E  2  . Either an LPA receptor 
antagonist or cyclooxygenase (COX) inhibitors abolish the 
stimulatory effects of P2X7 receptor activation on osteo-
genesis. We conclude that P2X7 receptors enhance osteo-
blast function through a cell-autonomous mechanism. 
Furthermore, a novel signaling axis links P2X7 receptors 
to production of LPA and COX metabolites, which in turn 
stimulate osteogenesis.
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acid (LPA) as well as cyclooxygenase (COX) metabolites. 
These lipid mediators then up-regulate expression of osteoblast 
marker genes and stimulate mineralization. Thus, we establish 
the existence of a P2X7-LPA signaling axis that regulates osteo-
blast differentiation and osteogenesis during skeletal remodel-
ing and mechanotransduction. 
  Results 
  Characteristics of calvariae from 
  P2rx7 
    /         mice 
  Mice lacking   P2rx7   exhibit decreased periosteal bone forma-
tion in the tibia and insensitivity of the ulna to mechanical load-
ing (  Ke et al., 2003  ;   Li et al., 2005  ). To further explore the role 
of this receptor in osteogenesis, we examined the calvariae of 
wild-type and   P2rx7 
   /       mice using microcomputed tomogra-
phy. Unlike long bones, which form primarily through endo-
chondral ossifi  cation, calvariae form through intramembranous 
ossifi  cation and are not subject to weight bearing. Surprisingly, 
we found that calvarial sutures were wider in   P2rx7 
   /       mice 
compared with age- and sex-matched wild-type controls ( Fig. 1 A ). 
There was no signifi  cant difference in calvarial thickness in the 
region of the suture. Quantitative analysis revealed that the 
cross sectional suture area between parietal bones was    40% 
greater in   P2rx7 
   /       mice compared with the wild type (  Fig. 1 B  ). 
Thus,   P2rx7 
   /       mice exhibit calvarial defects, which are evi-
dent at sutures which experience tensile strain caused by intra-
cranial pressure (  Henderson et al., 2005  ). 
  To investigate whether calvarial cells in situ express func-
tional P2X7 receptors, we assessed P2X7-induced pore forma-
tion ( Fig. 1 C ). Calvariae were removed from newborn wild-type 
and   P2rx7 
   /       mice. Parietal bones were incubated in 300   μ  M 
2   ,3  - O  -(4-benzoylbenzoyl)-ATP (BzATP; a relatively potent 
P2X7 agonist) or vehicle. Cells were stained with SYTO-13 
(green), a permeant dye that labels all cells, and ethidium bro-
mide (red), a normally impermeant dye that is taken up only 
when pores are present. The ectocranial surface of parietal bones 
was observed using bright fi  eld (  Fig. 1 C  , left) and confocal 
microscopy. All cells were stained with SYTO-13 (  Fig. 1 C  , 
middle, green). BzATP induced uptake of ethidium bromide in 
calvariae from wild-type but not   P2rx7 
   /       mice (  Fig. 1 C  , right, 
red). In contrast, when calvariae from wild-type and   P2rx7 
   /      
mice were not exposed to BzATP, ethidium bromide uptake was 
virtually undetectable (  n   =  6 – 8  calvariae;  unpublished  data). 
Thus, we show for the fi  rst time that functional P2X7 receptors 
are present on bone cells in situ. 
  Functional P2X7 receptors are expressed 
in osteoblasts in vitro 
  Previous in vitro studies have revealed that a subpopulation of 
rodent calvarial cells expresses P2X7 receptors (  Ke et al., 2003  ; 
  Panupinthu et al., 2007  ). In this paper, we found that a subpopu-
lation of marrow stromal cells isolated from rat long bones also 
expresses functional P2X7 receptors (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200708037/DC1). However, 
the identity of these subpopulations is not known. Moreover, it 
has not been established whether the effects of P2X7 receptors 
the skeleton, it is not known how these receptors infl  uence 
osteogenesis. Moreover, it is not known whether the phenotype 
of the   P2rx7 
   /       mouse is caused by an intrinsic defect in osteo-
blasts or by an indirect effect mediated by other cell types. 
In this regard, the P2X7 receptor is expressed in cells of the 
monocyte/macrophage lineage, including osteoclasts (  Naemsch 
et al., 2001  ), as well as some endocrine cell types. 
  In the present study, we discovered a cell-autonomous 
role for P2X7 receptors in bone formation. We show that activa-
tion of P2X7 receptors leads to production of lysophosphatidic 
  Figure 1.       Characterization of calvariae from   P2rx7 
    /        mice.   (A) Recon-
structed images obtained using microcomputed tomography show ecto-
cranial surface of the parietal bones from 9-mo-old male wild-type and 
  P2rx7 
    /        mice. Bar, 1 mm. Insets show sagittal sutures viewed in the 
coronal planes indicated by red arrowheads. Bar, 100   μ  m. Calvariae 
from   P2rx7 
    /        mice display wider sutures compared with the wild type. 
(B) Mean area of sagittal sutures was calculated from 10 coronal sec-
tions along the suture length. Larger suture area was observed in   P2rx7 
    /        
mice compared with the wild type (WT; *, P   <   0.05;   n   = 10  –  12 mice). 
Data are means   ±   SEM. (C) Calvariae were dissected from wild-type and 
  P2rx7 
    /        newborn mice and parietal bones were incubated in nominally 
divalent cation-free buffer for 10 min at 37  °  C. Paired samples were then 
exposed to 300   μ  M BzATP (depicted) or vehicle (not depicted) for 10 min. 
Fluorescent dyes, 5   μ  M SYTO-13 (cell-permeable nucleic acid stain), and 
20   μ  g/ml ethidium bromide (EtBr; normally impermeant DNA stain) were 
added for an additional 2 min in the presence of BzATP or vehicle. Bright 
ﬁ  eld images show ectocranial surfaces of calvariae (left). Confocal images 
of the same ﬁ  elds show all cells labeled with SYTO-13 (middle, green). 
BzATP induced uptake of ethidium bromide (indicating pore formation) 
by cells on the surface of calvariae from wild-type but not   P2rx7 
    /        mice 
(right, red). Ethidium bromide uptake in vehicle-treated calvariae from wild-
type and   P2rx7 
    /        mice was virtually undetectable (not depicted). Data 
are representative of four ﬁ   elds each from six to eight mice from three 
different litters. Bar, 100   μ  m.     861  P2X7-LPA AXIS STIMULATES OSTEOGENESIS   •   Panupinthu et al.
on bone formation in vivo are osteoblast autonomous. To inves-
tigate these questions, we used a well-characterized bone for-
mation assay using calvarial cells isolated from newborn rodents. 
In rat calvarial cell cultures, supplementation of the medium 
with 50   μ  g/ml ascorbic acid and 2 mM    -glycerophosphate 
induced osteoblast differentiation and bone nodule formation 
(  Fig. 2 A  ). Alkaline phosphatase (ALP) activity was detected 
using cytochemical staining (red). Mineral deposition was re-
vealed by staining with silver nitrate solution (von Kossa; black). 
After 14 d of supplementation, mineralized areas were centrally 
located within regions displaying ALP activity, indicating the 
presence of active osteoblasts. 
 We  fi rst determined expression of functional P2X7 recep-
tors in differentiated rat calvarial cell cultures using the pore for-
mation assay. Uptake of propidium iodide was monitored after 
treatment with 300   μ  M BzATP or vehicle (control). We exam-
ined confocal images in an xy plane near the midregion of nod-
ules (    25   μ  m above the substrate). Nuclei were visualized with 
SYTO-13 (  Fig. 2 B  , left). BzATP induced uptake of propidium 
iodide (  Fig. 2 B  , middle), and colocalization of SYTO-13 and 
propidium iodide was observed (  Fig. 2 B  , right). Intensity pro-
fi  les along the dotted lines revealed colocalization of SYTO-13 
and propidium iodide in cultures treated with BzATP but not in 
control. These data establish the presence of functional P2X7 re-
ceptors in bone nodule cells. When images were examined in an 
xy plane at the top of the nodule (in this case, 30   μ  m above the 
substrate), robust pore formation was observed in response to 
BzATP (  Fig. 2 C  , top). In contrast, cells located in the monolayer 
between nodules (6   μ  m above the substrate) did not exhibit pore 
formation, indicating that these less differentiated cells do not 
express functional P2X7 receptors (  Fig. 2 C  , bottom). 
  We next evaluated P2X7 receptor expression during the 
differentiation of rat and murine calvarial cells. When medium 
was supplemented with ascorbic acid and   -glycerophosphate, 
expression of   P2rx7   in cultures from wild-type mice was 
found to increase 2.9   ±   0.3-fold over 14 d (assessed using 
quantitative real-time RT-PCR;   n   = 3 independent experiments 
analyzed by paired   t   test; P   <   0.05). Expression of   P2rx7  
also increased during the differentiation of rat calvarial cells 
(levels assessed at days 0 and 7;   n   = 3 independent experiments; 
P   <   0.05). Collectively, these data demonstrate that the calvarial 
cells responsible for osteogenesis in vivo and in vitro express 
functional P2X7 receptors. 
  BzATP enhances osteogenesis in rat 
calvarial cell cultures 
  Having established that osteoblasts in calvarial cell cultures 
express functional P2X7 receptors, we next investigated the 
effects of receptor activation on osteogenesis. To monitor the 
  Figure 2.       Cells in bone nodules express P2X7 receptors.   Cultures of rat 
calvarial cells were supplemented with 50   μ  g/ml ascorbic acid and 2 mM 
    -glycerophosphate at day 0. (A) Selected cultures were ﬁ  xed and stained 
for ALP activity (red) and mineral deposition (black). Representative im-
age of a day-21 culture is shown at left. Higher magniﬁ  cation image of 
region indicated by dashed box shows individual nodules (right). Bars: 
(left) 1 mm; (right) 100   μ  m. (B) In other experiments, pore formation was 
assessed in live calvarial cell cultures (days 14  –  21). Cells were exposed to 
300   μ  M BzATP or vehicle (control). Pore formation was detected using con-
focal microscopy in a plane through the midregion of the nodule (    25   μ  m 
above substrate). All cells were stained with SYTO-13 (left, green). BzATP 
induced uptake of propidium iodide (middle, red) by cells within nodules. 
Below the images are linear intensity proﬁ  les, obtained where indicated 
by dashed lines, illustrating colocalization of probes in cultures exposed 
to BzATP. (C) The same BzATP-treated nodule shown in B was scanned in 
multiple focal planes parallel to the substrate. Overlay images and intensity 
proﬁ  les are from focal planes near the top (in this case, 30   μ  m above the 
substrate) and bottom (6   μ  m above the substrate) of the nodule. BzATP 
induced pore formation in cells speciﬁ  cally located in the nodule but not 
in the monolayer between nodules. Data in B and C are representative of 
four independent preparations. Bars, 100   μ  m.     
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and osteocalcin at 14 and 28 d (  Fig. 3, D and E  ). Expression of 
the gene encoding osteocalcin (marker of late-stage osteoblast 
differentiation) was dramatically enhanced by BzATP at 28 d. 
Thus, BzATP acts on cells of the osteoblast lineage to up-
regulate the genes encoding osterix and osteocalcin and to 
promote osteogenesis. 
  It is known that BzATP activates several P2 nucleotide re-
ceptors in addition to P2X7 (  North, 2002  ). Thus, we investigated 
which P2 receptor subtypes mediate the stimulatory effects of 
BzATP on bone formation using UTP, an agonist for several P2Y 
receptors but ineffective at all P2X receptors (  Burnstock, 2007  ). 
Moreover, ALP present on the surface of osteoblasts can hydro-
lyze nucleotides, causing release of P  i   that promotes mineraliza-
tion at suffi  ciently high concentrations. Although 100   μ  M BzATP 
increased mineral deposition and ALP activity, 100   μ  M UTP did 
not (  Fig. 3, F  –  H  ). Similarly, an equivalent concentration of P  i  
  Figure 3.       BzATP enhances osteogenesis.   (A) Rat calvarial cells were differentiated in medium containing physiological concentrations of Ca 
2+   and Mg 
2+  . 
Cultures were treated with 100   μ  M BzATP or vehicle (control) beginning at day 0 for up to 28 d. BzATP enhanced ALP activity and mineral deposition in rat 
calvarial cell cultures. Bar, 1 mm. (B and C) Mineralized area (B) and ALP-positive area (C) were quantiﬁ  ed using 2D image analysis. Areas are expressed 
as a percentage of total area. BzATP promoted mineralization and accelerated the appearance of ALP activity. Data are means   ±   SEM (  n   = 4 independent 
preparations). *, signiﬁ  cant difference compared with control (P   <   0.05). (D and E) Next, total RNA was isolated from differentiated rat calvarial cell 
cultures at the times indicated. Expression levels of genes encoding osterix (D) and osteocalcin (E) were analyzed using real-time RT-PCR. Data are ex-
pressed relative to values in control cultures at day 14. BzATP increased expression of both genes. Data are means   ±   SEM (  n   = 3 independent prepara-
tions). *, signiﬁ  cant effect of BzATP compared with control at the corresponding time (P   <   0.05). (F) Cultures were treated with vehicle (control), 100   μ  M 
BzATP, 100   μ  M UTP (P2Y-selective agonist), or an equivalent concentration of P  i   (300   μ  M) beginning at day 0 for 14 d. Bar, 1 mm. (G and H) BzATP, 
but not UTP or P  i  , promoted mineralization (G) and ALP activity (H). Data are means   ±   SEM (  n   = 4 independent preparations). *, signiﬁ  cant difference 
compared with control (P   <   0.05).     
formation of bone nodules, mineralized and ALP-positive areas 
were assessed at 7-d intervals. As expected, both parameters 
increased in the presence of ascorbic acid and    -glycero-
phosphate over 28 d in control cultures. 100   μ  M BzATP stimu-
lated mineralization and ALP activity (  Fig. 3 A  ). Analysis of 
mineralized area indicated that BzATP signifi  cantly enhanced 
the extent of mineralization compared with the control from 
14  –  28 d, with a 40% increase at day 28 (  Fig. 3 B  ). In addi-
tion, BzATP accelerated the development of ALP activity, 
with signifi  cant increases at 14 and 21 d but reaching the 
same level by 28 d (  Fig. 3 C  ). Data from all bone formation 
assays were pooled from at least three independent experiments. 
  We next assessed expression of osteoblast marker genes 
in rat calvarial cell cultures using real-time RT-PCR. Consis-
tent with its effects on nodule formation, 100   μ  M BzATP sig-
nifi  cantly up-regulated levels of transcripts encoding osterix 863  P2X7-LPA AXIS STIMULATES OSTEOGENESIS   •   Panupinthu et al.
difference was observed in the absence of exogenous nucleotides 
provides further evidence for constitutive nucleotide release. 
  We next investigated whether the difference in osteogene-
sis in cultures from wild-type and   P2rx7 
   /       mice  could  arise 
from changes in the proliferation or survival of calvarial cells. 
However, DNA analysis revealed no signifi  cant difference in 
cell numbers between   P2rx7 
   /       and wild-type cultures at 0 and 
28 d (  Fig. 4 D  ). These data and those presented in   Fig. 3   indi-
cate that P2X7 receptors stimulate bone formation, possibly by 
enhancing osteoblast differentiation. 
  Gene expression in cultures of calvarial 
cells from wild-type and   P2rx7 
    /         mice 
  To explore the role of   P2rx7   in osteoblast differentiation, we 
assessed expression levels of marker genes in cultures from 
wild-type and   P2rx7 
   /       mice at 7-d intervals up to 28 d, with-
out exogenous nucleotides. There was no signifi  cant differ-
ence in levels of Runx2 transcripts in wild-type and   P2rx7 
   /      
cultures (  Fig. 5  ). Osterix transcript levels were dramatically 
suppressed in   P2rx7 
   /       cultures at day 7, a time that corre-
sponded to the initiation of nodule formation. Expression of 
the gene encoding bone sialoprotein was diminished fi  vefold 
in   P2rx7 
   /       cultures at 7 d, closely refl  ecting the changes in 
osterix expression. Furthermore, transcript levels of osteo-
calcin were markedly suppressed from 7  –  21 d in   P2rx7 
   /      
cultures (2  –  13-fold). 
  Because there is lineage allocation during differentiation 
of mesenchymal cells, we next investigated the expression of 
adipocyte and chondrocyte markers. At day 7, transcript levels 
of the adipocyte marker peroxisome proliferator-activated 
(300   μ  M) had no effect. Thus, activation of P2Y receptors is not 
suffi  cient to stimulate osteogenesis, and the modest increase in P  i  
levels from nucleotide hydrolysis cannot account for the enhance-
ment of mineralization observed. 
 To evaluate the role of endogenous nucleotides, rat calvarial 
cell cultures were differentiated in the absence of exogenous 
nucleotides with and without apyrase, a diphosphohydrolase 
that breaks down extracellular nucleotides. 10 units/ml apy-
rase decreased ALP activity (at 14 d, ALP-positive area was 
50   ±   3% in control cultures vs. 39   ±   2% in cultures treated 
with apyrase;   n   = 3 independent experiments; P   <   0.05). This 
fi  nding is consistent with constitutive release of endogenous 
nucleotides from calvarial cells, which has been reported pre-
viously in an osteoblast-like cell line (  Buckley et al., 2003  ). 
  Diminished mineralization and ALP activity 
in cultures from   P2rx7 
    /         mice 
  To further investigate the role of P2X7 receptors in osteogene-
sis, we compared nodule formation in cultures of calvarial cells 
from wild-type and   P2rx7 
   /       mice. Medium was supplemented 
with ascorbic acid and     -glycerophosphate without exogenous 
nucleotides (in contrast to the experiments shown in   Fig. 3  , 
where BzATP was added). Cultures from  P2rx7 
   /      mice showed 
a marked decrease in mineralization compared with wild-type 
murine cultures, with a 33% reduction at day 28 ( Fig. 4, A and B ). 
Moreover, the development of ALP activity was delayed in cul-
tures from   P2rx7 
   /       mice, with signifi  cantly less activity at 14 
and 21 d (  Fig. 4, A and C  ). Thus, osteogenesis is diminished in 
cultures from   P2rx7 
   /       mice, supporting a role for P2X7 recep-
tors in stimulating bone formation. Moreover, the fact that this 
  Figure 4.       Reduced osteogenesis in cultures of cal-
varial cells from   P2rx7 
    /        mice.   (A) Calvarial cells 
from wild-type and   P2rx7 
    /        mice were cultured in 
medium containing physiological concentrations of 
Ca 
2+   and Mg 
2+  . At day 0, culture medium was supple-
mented with ascorbic acid and     -glycerophosphate 
without exogenous nucleotides. Images show repre-
sentative micromass cultures (equivalent ﬁ  elds).  Bar, 
0.5 cm. (B and C) Calvarial cell cultures from   P2rx7 
    /        
mice showed decreased mineral deposition (B) and 
delayed development of ALP activity (C) compared 
with wild-type cultures. Data are means   ±   SEM (  n   = 3 
independent preparations). *, signiﬁ  cant  difference 
compared with wild type (P   <   0.05). (D) DNA content 
of selected cultures was assessed using HOECHST 
33342. Data are expressed relative to DNA content 
in wild-type cultures at day 0. As expected, DNA 
content increased from day 0 to 28, however there 
was no signiﬁ   cant difference between cultures from 
wild-type and   P2rx7 
    /        mice. Data are means   ±   SEM 
(  n   = 3  –  4 independent preparations). *, signiﬁ  cant dif-
ference compared with day 0 (P   <   0.05).     JCB • VOLUME 181 • NUMBER 5 • 2008  864 
differentiation in   P2rx7 
   /       cell cultures. Collectively, our fi  nd-
ings from the rat and murine systems (  Figs. 2  –  5  ) establish that 
P2X7 receptors promote osteogenesis through a cell-autonomous 
mechanism by directing cells toward the osteoblast lineage. 
  P2X7 receptors couple to production of 
LPA through activation of phospholipases 
  In our previous study, lipid signaling was implicated in the path-
way underlying P2X7-induced membrane blebbing of calvarial 
cells (  Panupinthu et al., 2007  ). Therefore, we used a biochemical 
receptor      (PPAR  )  were  signifi  cantly increased (approx-
imately threefold) in cultures from   P2rx7 
   /       compared  with 
wild-type mice (  Fig. 5  ). Similarly, expression of the gene en-
coding lipoprotein lipase, which is regulated by PPAR   ,  was 
increased in   P2rx7 
   /       cultures at day 7. In contrast, the ab-
sence of P2X7 receptors did not signifi  cantly affect levels of 
the chondrocyte marker genes encoding Sox9 and collagen 
type II     1. These data indicate simultaneous up-regulation of 
adipocyte differentiation and down-regulation of osteoblast 
  Figure 5.       Gene expression in cultures of calvarial cells from wild-type 
and   P2rx7 
    /        mice.   Cultures of calvarial cells from wild-type and   P2rx7 
    /        
mice were supplemented at day 0 with ascorbic acid and     -glycerophos-
phate without exogenous nucleotides. Total RNA was isolated at the times 
indicated. Real-time RT-PCR was used to analyze expression levels of genes 
encoding osteoblast markers (Runx2, osterix, bone sialoprotein, and osteo-
calcin), adipocyte markers (PPAR     and lipoprotein lipase), and chondro-
cyte markers (Sox9 and collagen type II     1). Data are expressed relative to 
values in wild-type cultures at day 0. Cultures from   P2rx7 
    /        mice showed 
signiﬁ  cant decreases in expression levels of osteoblast marker genes, ex-
cept Runx2. Cultures from   P2rx7 
    /        mice also showed increased levels 
of adipocyte markers at day 7. However, there were no differences in 
levels of chondrocyte markers. Data are means   ±  SEM (  n   = 3 independent 
preparations). *, signiﬁ  cant difference compared with wild type at the cor-
responding time (P   <   0.05).     
  Figure 6.       P2X7 receptors activate PLD and PLA  2   leading to production of 
LPA.   (A) Representative thin layer chromatograph illustrating the following 
reference lipids: PG, phosphatidylglycerol; LPG, lysophosphatidylglycerol; 
PA, phosphatidic acid; LPA; PC, phosphatidylcholine; and LPC, lysophos-
phatidylcholine (phosphatidylethanolamine was omitted for clarity). (B) Rat 
calvarial cells were labeled with 1   μ  Ci/ml [ 
14  C]glycerol at 37  °  C for 18 h. 
Cells were then incubated for 10 min at 37  °  C with 1% vol/vol 1-butanol 
(PLD inhibitor), 1% vol/vol   tert  -butanol (inactive analogue of 1-butanol), 10   μ  M 
BEL (PLA  2   inhibitor), or vehicle. 300   μ  M BzATP or its vehicle (control) was 
then added and cultures were incubated for an additional 20 min in the con-
tinued presence of inhibitors. Lipids were extracted from the cell layer and 
separated by thin layer chromatography. The percentages of radioactivity in 
[ 
14  C]phosphatidic acid, [ 
14  C]LPA, and [ 
14  C]phosphatidylcholine were deter-
mined. (C) Calvarial cells isolated from wild-type (WT) and   P2rx7 
    /        mice 
were labeled with [ 
14  C]glycerol. 300   μ  M BzATP or its vehicle (control) was 
added and cultures were incubated for 20 min. Lipids were extracted from 
the cell layer and separated by thin layer chromatography. The percentages 
of radioactivity in [ 
14  C]LPA and [ 
14  C]phosphatidylcholine were determined. 
Data are means   ±   SEM (  n   = 3 independent preparations). *, signiﬁ  cant dif-
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of P2X7 receptors leads to production of the potent lipid mediator 
LPA through stimulation of PLD and PLA  2   activity. 
  Role of lipid signaling pathways in mediating 
BzATP-induced osteogenesis 
  LPA acts through the specifi  c G protein  –  coupled receptors 
LPA1  –  5. LPA1 is widely distributed and appears to be the pre-
dominant receptor subtype present in cells of the osteoblast 
lineage (  Masiello et al., 2006  ). We tested directly whether LPA 
signaling is involved in P2X7-induced osteogenesis. 
  We began by assessing the effectiveness and specifi  city of 
the LPA1/3 receptor antagonist VPC-32183 ( Heasley et al., 2004 ) 
in rat calvarial cell cultures. Because LPA receptors signal through 
PLC (  Mills and Moolenaar, 2003  ), we monitored LPA-induced 
elevation of [Ca 
2+ ] i   (cytosolic free Ca 
2+   concentration).  When 
cells were loaded with fl  uo-4 and monitored using confocal 
microscopy, 100 nM LPA was found to induce a transient in-
crease in [Ca 
2+ ] i   (  Fig. 7 A  ). Subsequent stimulation with 100   μ  M 
UTP caused a similar increase in [Ca 
2+ ] i   because of activation 
of P2Y receptors, which also couple through G proteins to PLC. 
1   μ  M VPC-32183 suppressed the Ca 
2+   response to LPA without 
affecting the UTP response (  Fig. 7 B  ), indicating specifi  city of 
this antagonist for LPA receptors. Quantifi  cation of peak ampli-
tudes revealed that the LPA-induced Ca 
2+   response was virtually 
abolished by VPC-32183 (  Fig. 7 C  , left), whereas VPC-32183 did 
not affect the UTP-induced elevation of [Ca 
2+ ] i   ( Fig.  7  C ,  right). 
approach to directly investigate whether P2X7 receptor ac-
tivation leads to the production of LPA. Rat calvarial cells were 
labeled with [ 
14  C]glycerol overnight and then incubated with 
300   μ  M BzATP or vehicle (control) for 20 min. Cells were col-
lected and total lipids were separated using thin layer chromatog-
raphy (  Fig. 6 A  ). BzATP induced a signifi  cant increase in levels 
of phosphatidic acid (PA;   Fig. 6 B  , top). The phospholipase D 
(PLD) inhibitor 1-butanol (1% vol/vol) completely inhibited the 
production of phosphatidic acid induced by BzATP. In contrast, 
its inactive analogue   tert  -butanol had little effect. Moreover, 
10   μ  M of the PLA  2   inhibitor bromoenol lactone (BEL) had no 
signifi  cant effect on phosphatidic acid synthesis. Importantly, 
BzATP stimulated production of LPA (  Fig. 6 B  , middle). This 
effect was abolished by 1-butanol as well as by BEL, whereas 
  tert -butanol had no signifi  cant effect. In the absence of phospho-
lipase inhibitors, BzATP caused a signifi  cant decrease in levels 
of phosphatidylcholine (PC,   Fig. 6 B  , bottom), which is con-
sistent with phosphatidylcholine being a preferred substrate of 
PLD (  Frohman et al., 1999  ). In accord, there were no signifi  cant 
changes in phosphatidylethanolamine levels (Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200708037/DC1). 
  As in rat calvarial cells, BzATP stimulated production of 
LPA in wild-type murine cells (  Fig. 6 C  , left), together with a 
corresponding decrease in phosphatidylcholine levels (  Fig. 6 C  , 
right). In contrast, BzATP failed to induce LPA production in cells 
from   P2rx7 
   /       mice. These data establish directly that activation 
  Figure 7.       The LPA receptor antagonist VPC-
32183 inhibits LPA-induced elevation of [Ca 
2+  ]  i  .   
Rat calvarial cells were isolated and cultured 
for 7  –  9 d on 35-mm glass bottom dishes, with-
out ascorbic acid or     -glycerophosphate. Cells 
were loaded with the Ca 
2+  -sensitive probe ﬂ  uo-4 
and ﬂ   uorescence intensity was measured us-
ing confocal microscopy. Cells were bathed in 
serum-free medium at room temperature for 
20 min with vehicle or 1  μ  M VPC-32183 (LPA1/3 
receptor antagonist) and then challenged se-
quentially with 100 nM LPA and 100   μ  M UTP 
(which activates calcium mobilizing P2Y re-
ceptors on osteoblasts). (A) Micrographs of a 
representative ﬁ  eld in a vehicle-treated culture 
show basal ﬂ   uorescence (a), peak of the re-
sponse to LPA (b), before adding UTP (c), and 
peak response to UTP (d). Both LPA and UTP 
caused transient increase in the ﬂ  uorescence 
intensity of ﬂ   uo-4. Bar, 10   μ  m. (B) Graphs 
show time course of [Ca 
2+  ]  i   changes in the 
whole ﬁ   eld. Data are expressed as percent-
ages of the basal ﬂ   uorescence intensity at 
time 0. Cells were challenged with 100 nM 
LPA and 100   μ  M UTP at the times indicated 
by the horizontal bars beneath the graphs. 
a  –  d indicate the times of capture of the images 
shown in A. (C) Peak amplitudes of Ca 
2+   re-
sponses to LPA and UTP were calculated. Data 
are the maximum elevation above basal ex-
pressed as a percentage of basal. VPC-32183 
signiﬁ   cantly suppressed the Ca 
2+   response 
induced by 100 nM LPA (left) but had no ef-
fect on the subsequent response to UTP (right). 
Data are means   ±   SEM (  n   = 3 independent 
preparations). *, signiﬁ   cant effect of VPC-
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BzATP on mineral deposition (  Fig. 8, A and B  ). In contrast, the 
LPA receptor antagonist had only a modest effect on the BzATP-
induced increase in ALP activity (  Fig. 8, A and C  ). In addition, 
VPC-32183 itself had no effect on cell numbers (Fig. S3 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200708037/DC1). 
In some experiments, total RNA was collected and real-time RT-
PCR analysis was performed. VPC-32183 abolished the increase 
in expression of osterix and osteocalcin induced by BzATP 
(  Fig. 8 D  ). These data indicate that BzATP-induced osteogenesis 
is dependent on pathways downstream of LPA receptors. 
  It is possible that BzATP-induced osteogenesis involves 
signaling pathways in addition to LPA. Activation of PLA  2  leads 
to production of eicosanoids such as prostaglandin E  2   (PGE 2 ), 
which is known to stimulate bone formation in vitro and in vivo 
(  Flanagan and Chambers, 1992  ;   Yoshida et al., 2002  ). There-
fore, we determined the effects of BzATP on synthesis of PGE  2 . 
After 5 min, 300   μ  M BzATP signifi  cantly increased PGE  2   re-
lease from rat calvarial cell cultures (  Fig. 9 A  ). 10   μ  M ibupro-
fen, which inhibits both COX-1 and -2, blocked the effects of 
BzATP on PGE  2   synthesis. In contrast, VPC-32183 did not in-
hibit PGE  2   production  ( n   = 3 independent experiments; unpub-
lished data), indicating that BzATP-induced prostaglandin 
synthesis does not depend on LPA receptor activation. 
  We next explored the role of COX in P2X7-induced osteo-
genesis. Rat calvarial cells were differentiated with or without 
100   μ  M BzATP, and in the presence of 10   μ  M ibuprofen, 10   μ  M 
NS-398 (a selective COX-2 inhibitor), or vehicle for 14 d. Like 
VPC-32183, NS-398 itself had no effect on cell numbers (Fig. 
S3 B). Again, BzATP stimulated mineralization and ALP activity 
(  Fig. 9 B  ). Similar to the actions of VPC-32183, COX inhibitors 
abolished the effects of BzATP on mineralization and osteo-
calcin expression while only slightly suppressing ALP activity 
(  Fig. 9, C  –  E  ). Activation of P2X7 receptors did not signifi  cantly 
alter expression of COX-2 at 14 d (mRNA levels in BzATP-
treated cells were 122  ±  5% of control;  n  = 3 independent experi-
ments; P   >   0.05). However, it is possible that BzATP transiently 
alters COX-2 expression at earlier times. Collectively, these data 
implicate eicosanoid signaling along with LPA in mediating 
P2X7-induced osteogenesis (  Fig. 10  ). 
  Discussion 
  P2X7 receptors promote osteogenesis 
in vivo and in vitro 
  Mesenchymal cells within cranial sutures proliferate and differ-
entiate to sustain the osteoblast population and form new bone 
(  Morriss-Kay and Wilkie, 2005  ), processes which are stimu-
lated at least in part by mechanical tension (  Hou et al., 2007  ). 
In the present study, microcomputed tomography revealed wider 
sutures in adult   P2rx7 
   /       mice compared with the wild type, 
which is consistent with reduced osteogenesis at the suture. 
In contrast, there was no apparent difference in the size of fonta-
nelles of wild-type and   P2rx7 
   /       mice at birth (unpublished 
data), although P2X7 receptors are expressed in the cranial bones 
and vertebrae of embryonic day 19 rat embryos (  Collo et al., 
1997  ). This phenotype is in keeping with the characteristics of 
long bones in   P2rx7 
   /       mice, which display reduced periosteal 
  Having demonstrated the effectiveness and specifi  city of 
VPC-32183 in osteoblasts, we next investigated the effects of this 
LPA receptor antagonist on BzATP-induced osteogenesis. Rat 
calvarial cells were differentiated with or without 100  μ M BzATP, 
and cultures were also treated with 1   μ  M VPC-32183 or its vehi-
cle for 14 d. As expected, BzATP enhanced mineralization and 
ALP activity. Importantly, VPC-32183 abolished the effect of 
  Figure 8.       VPC-32183 suppresses BzATP-enhanced mineralization.   During 
differentiation, rat calvarial cells were treated with 1   μ  M VPC-32183 
or its vehicle and 100   μ  M BzATP or its vehicle (control) for 14 d. (A) Cul-
tures were ﬁ  xed and stained for ALP activity and mineral deposition. Bar, 
1 mm. (B) VPC-32183 suppressed BzATP-enhanced mineralization without 
signiﬁ  cantly affecting control cultures. (C) ALP activity was not signiﬁ  cantly 
affected by VPC-32183. (D) Expression levels of genes encoding osterix 
and osteocalcin were analyzed using real-time RT-PCR. Data are expressed 
relative to values in vehicle-treated control cultures. VPC-32183 abolished 
the effects of BzATP on osterix and osteocalcin expression. Data are means   ±   
SEM (  n   = 3 independent preparations). *, signiﬁ  cant effect of BzATP com-
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  Nakamura et al., 2000  ) and activates the early growth response 
protein Egr-1 (  Pines et al., 2003  ). Moreover, ATP and UTP at 
low concentrations have been reported to inhibit bone nodule 
formation by rat calvarial osteoblasts (  Hoebertz et al., 2002  ), 
an effect which is mediated by P2Y2 receptors and the release 
of pyrophosphate (  Orriss et al., 2007  ). 
circumference which is more evident in adult (9 mo) than young 
(2 mo) mice (  Ke et al., 2003  ). The late onset of differences be-
tween the skeletons of   P2rx7 
   /       and wild-type mice is consis-
tent with a role for   P2rx7   in mechanically stimulated bone 
remodeling rather than in development per se. 
 We  identifi  ed functional P2X7 receptors in cells of the os-
teoblast lineage in situ. This fi  nding rules out the possibility that 
receptor expression is induced by in vitro culture, as reported 
previously for P2Y2 receptors in cells from rat submandibular 
salivary gland (  Turner et al., 1997  ). Functional P2X7 receptors 
were present in cells located on the ectocranial surface of cal-
variae, which undergoes active osteogenesis during cranial ex-
pansion. In vitro, P2X7 receptors are expressed in a subpopulation 
of calvarial cells and bone marrow stromal cells. Interestingly, 
calvarial cells expressing functional P2X7 receptors were asso-
ciated with bone-like nodules, which is consistent with their ex-
pression in differentiated osteoblasts and with a role for these 
receptors in osteogenesis. 
  In addition to effects mediated by P2X7 receptors, nucleo-
tides may regulate osteogenesis via interactions with other P2 
receptor subtypes as well as by providing a source of P  i   (which 
promotes mineralization) and pyrophosphate (which inhibits 
mineralization). Thus, effects of nucleotides on osteoblasts 
likely differ depending on which P2 receptor subtypes are acti-
vated. At concentrations too low to activate P2X7 receptors but 
suffi  cient to activate several other P2 receptor subtypes, ATP 
stimulates the proliferation of osteoblast-like cells (  Shimegi, 1996 ; 
  Figure 9.       COX inhibitors suppress BzATP-enhanced mineralization in rat calvarial cell cultures.   (A) Rat calvarial cells were incubated in serum-free medium 
for 15  –  18 h and then treated for 10 min at 37  °  C with 10   μ  M ibuprofen (COX inhibitor) or vehicle. 300   μ  M BzATP or its vehicle (control) was then added 
and cultures were incubated for an additional 5 min. Media were collected and levels of PGE  2   assessed. Data are expressed as percentages of PGE  2   
levels in vehicle-treated control. *, signiﬁ  cant effect of BzATP compared with corresponding control (P   <   0.05;   n   = 3 independent preparations). (B) Dur-
ing differentiation, rat calvarial cells were treated with 10   μ  M ibuprofen, 10   μ  M NS-398 (COX-2 inhibitor), or vehicle and also with 100   μ  M BzATP or its 
vehicle (control) for 14 d. Cultures were ﬁ  xed and stained for ALP activity and mineral deposition. Bar, 1 mm. (C and D) Ibuprofen and NS-398 abolished 
the effects of BzATP on mineralization (C) and moderately suppressed ALP activity (D). (E) Osteocalcin expression was quantiﬁ  ed by real-time RT-PCR. Data 
are expressed relative to values in vehicle-treated control. NS-398 abolished the effect of BzATP on osteocalcin expression. Data are means   ±   SEM (  n   = 3 
independent preparations). *, signiﬁ  cant effect of BzATP compared with control (P   <   0.05).     
  Figure 10.       Proposed P2X7-LPA signaling axis promoting osteogenesis.   
Activation of P2X7 receptors on cells of the osteoblast lineage by endog-
enous ATP or exogenous BzATP leads to production of LPA through a 
pathway involving PLD and PLA  2  . In addition, activation of PLA  2   leads 
to production of COX metabolites such as prostaglandins (PG). LPA and 
prosta  glandins then bind to their receptors on the same or neighboring 
cells to induce expression of osteoblast genes such as osterix and osteocalcin. 
Up-regulation of these genes in turn induces osteogenesis by promoting 
differentiation and mineralization.     JCB • VOLUME 181 • NUMBER 5 • 2008  868 
receptors in lymphoid and other cell types confers the ability to 
grow in the absence of serum (  Baricordi et al., 1999  ;   Adinolfi   
et al., 2005  ), possibly because of the production of LPA. 
  Activation of PLA  2   is a key step in the production of LPA 
as well as the formation of eicosanoids. In the present study, 
we showed that the COX pathway is involved in P2X7-induced 
osteogenesis in concert with LPA receptor signaling. In keeping 
with our fi  ndings, bone marrow  –  derived osteoblasts exhibit re-
duced osterix expression in the absence of the gene encoding 
COX-2 (  Zhang et al., 2002  ). Interestingly, mechanically in-
duced release of PGE  2   is impaired in osteoblasts from   P2rx7 
   /      
mice (  Li et al., 2005  ). Moreover, release of ATP in response 
to mechanical stimulation leads to the production of PGE  2   in 
MC3T3-E1 osteoblastic cells (  Genetos et al., 2005  ). 
  Based on our pore formation and receptor expression 
studies, it appears that differentiated cells of the osteoblast lin-
eage express functional P2X7 receptors. However, studies of 
marker gene expression indicated that these receptors regulate 
the differentiation of less mature cells. In this regard, LPA and 
eicosanoids produced in response to activation of P2X7 recep-
tors on mature osteoblasts may act as autocrine factors on the 
same cells. In addition, these mediators could act as paracrine 
factors to stimulate the differentiation of less mature cells in the 
surrounding region. Collectively, we have identifi  ed two lipid 
signaling pathways, involving LPA and eicosanoids, underlying 
P2X7-induced osteogenesis. 
  Physiological relevance of P2X7-induced 
osteogenesis 
  ATP is released from bone cells in vitro through constitutive 
and inducible mechanisms (  Buckley et al., 2003  ;   Genetos et al., 
2005 ).  In   P2rx7 
   /       mice, osteogenesis (  Ke et al., 2003  ) and ana-
bolic responses to mechanical loading (  Li et al., 2005  ) are im-
paired, indicating that release of ATP into the bone extracellular 
fl  uid occurs in vivo. Our present data are consistent with release 
of endogenous ATP stimulating osteogenesis in vitro. In this re-
gard, it has been shown that the differentiation of rat calvarial 
cells is accompanied by a fi  vefold increase in cytosolic ATP 
content at 10  –  14 d (  Komarova et al., 2000  ). However, the con-
centration of ATP in the extracellular compartment depends 
upon the balance between the release of ATP and its degradation 
by ectonucleotidases. Therefore, it is conceivable that constitu-
tive ATP release in vivo is insuffi  cient to activate P2X7 receptors, 
whereas enhanced release arising from mechanical stimulation 
is suffi  cient to trigger P2X7 signaling. 
  In keeping with a role for P2X7 in mechanotransduction, 
differences in osteogenesis in   P2rx7 
   /       mice are most notice-
able at sites in long bones that experience large mechanical 
strain caused by weight bearing (  Ke et al., 2003  ). It is known 
that osteogenesis on periosteal surfaces correlates with applied 
stress (  Robling et al., 2006  ). In this paper, we characterized an 
additional defect in the   P2rx7 
   /       mouse involving impaired su-
tural bone growth. Tensile forces caused by intracranial pres-
sure are thought to trigger the growth of bone at sutures (  Hou et al., 
2007  ). Therefore, it is possible that mechanical strain induces 
local release of ATP, which then activates P2X7 receptors on 
cells of osteoblast lineage, inducing osteogenesis. 
  Regulation of gene expression by P2X7 
receptors during osteogenesis 
  Characterization of mice lacking genes encoding Runx2 and 
osterix has established the roles of these transcription factors as 
master regulators of osteoblast differentiation (  Ducy et al., 1997  ; 
  Nakashima et al., 2002  ).   Runx2 
   /       mice also exhibit a defect in 
the differentiation of hypertrophic chondrocytes (  Enomoto et al., 
2000  ). We found that there was signifi  cant reduction in osterix, 
but not Runx2, mRNA in calvarial cell cultures from   P2rx7 
   /      
mice compared with the wild type. Runx2 functions upstream of 
osterix and can directly regulate its expression (  Nishio et al., 
2006  ). Thus, it is likely that P2X7 receptors up-regulate ex-
pression of osterix and promote osteoblast differentiation down-
stream of Runx2 or via effects on Runx2 activity that can be 
regulated by phosphorylation (  Ge et al., 2007  ). Moreover, in 
  P2rx7 
   /       calvarial cell cultures, we observed down-regulation of 
the gene encoding osteocalcin, which is known to be regulated 
by osterix (  Nakashima et al., 2002  ). 
  We found that deletion of   P2rx7   not only suppresses osteo-
blast differentiation but enhances expression of the adipocyte 
markers PPAR     and lipoprotein lipase. Bipotential mesenchy-
mal cells can differentiate into cells of the osteoblast or adipo-
cyte lineage depending on levels of osterix and PPAR   expression 
(  Ali et al., 2005  ). Thus, it appears that activation of P2X7 recep-
tors directs cells toward the osteoblast lineage. Like Runx2 and 
osterix in osteoblasts, Sox9 regulates chondrocyte differentiation 
through activation of several genes including   Col2a1   ( Lefebvre 
et al., 1997  ). We found that there was no signifi  cant difference in 
  Sox9   and   Col2a1   expression in calvarial cells from   P2rx7 
   /      
compared with wild-type mice at any time during differentiation. 
It has been shown that Sox9 in embryonic osteochondroprogeni-
tor cells regulates both intramembranous and endochondral ossi-
fi  cation; however, expression of Sox9 precedes that of Runx2 
and osterix (  Akiyama et al., 2005  ). Collectively, P2X7 receptors 
appear to regulate osteogenesis at a stage later than Sox9 induction, 
which is consistent with the skeletal phenotype of the   P2rx7 
   /      
mouse in which long bone length and presumably chondrocyte 
differentiation are unaffected (  Ke et al., 2003  ). 
  The role of lipid signaling pathways in 
P2X7-induced osteogenesis 
  In the present study, we have shown directly that BzATP in-
duces production of phosphatidic acid (via activation of PLD) 
and LPA (via activation of PLD and PLA  2  ) in osteoblasts. LPA 
is a soluble mediator that acts on G protein  –  coupled receptors, 
fi  ve of which, LPA1  –  5, are currently identifi  ed in mammals 
(  Anliker and Chun, 2004  ;   Lee et al., 2006  ). LPA binds to its re-
ceptors on cells of the osteoblast lineage and subserves many 
functions, such as promoting proliferation, inducing migration, 
and regulating morphology (  Grey et al., 2001  ;   Masiello et al., 
2006  ;   Panupinthu et al., 2007  ). 
  It is possible that the role of LPA in osteogenesis has not 
been recognized previously because LPA is abundant in serum 
used to supplement media for in vitro bone formation assays. 
Moreover, production of LPA may explain previous reports of 
apparently anomalous responses to P2X7 receptor activation in 
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obtained from rats and the system has been extensively characterized, 
rat cultures were used for most experiments. Cells from wild-type and 
  P2rx7 
    /        mice were used to assess the effect of P2X7 loss-of-function on 
osteogenesis. For rat cultures, freshly isolated calvarial cells were plated 
in T-25 ﬂ   asks at a density of 1.5   ×   10 
4   cells/cm 
2   and maintained in 
    -MEM with 10% FBS and 1% antibiotic solution (culture medium). After 
3 d, undifferentiated cultures were trypsinized and seeded on six-well 
plates at a density of 3   ×   10 
4   cells/cm 
2  . After an additional 3 d, culture 
medium was supplemented with 50   μ  g/ml ascorbic acid and 2 mM 
    -glycerophosphate (deﬁ   ned as day 0). Cells were cultured for up to 
4 wk (day 28) together with test substances or vehicles in supplemented 
medium, which was changed every 2  –  3 d. In some experiments, bone 
marrow stromal cells were obtained from femurs and tibias of 1-d-old rats 
as previously described (  Maniatopoulos et al., 1988  ). 
  For murine cultures, freshly isolated calvarial cells were seeded on 
six-well plates at a density of 1.5   ×   10 
4   cells/cm 
2   in culture medium. After 
3 d, cells were trypsinized and transferred to 12-well plates, with each well 
containing 5   ×   10 
4   cells in a 150-  μ  l drop of culture medium. After 24 h, 
culture medium was added to the micromasses. After an additional 2 d, 
cultures were supplemented with 50   μ  g/ml ascorbic acid and 2 mM   
  -glycerophosphate and maintained for up to 28 d. 
  In vitro pore formation assay 
  Rat calvarial cells were isolated and plated in culture medium on a two-well 
Lab-Tek Chamber Slide (Thermo Fisher Scientiﬁ  c) at a density of 3   ×   10 
4   
cells/cm 
2  . Cultures were differentiated with ascorbic acid and     -glycero-
phosphate for 14  –  21 d. Some experiments were also performed using un-
differentiated cells isolated from long bones of newborn rats. Pore formation 
assay was performed in nominally divalent cation-free buffer with BzATP or 
its vehicle as described in In situ pore formation assay and confocal micros-
copy. In vitro studies were performed using propidium iodide rather than 
ethidium bromide. 
  Cytochemical analyses of ALP activity and mineral deposition 
  Calvarial cell cultures were ﬁ  xed with 4% neutral buffered formalin over-
night at 4  °  C. ALP activity was revealed using a mixture of 0.25 mM naph-
thol AS-MX phosphate and 1.25 mM Fast Red B salt in 0.1 M Tris-HCl, pH 8, 
for 1 h in the dark. To demonstrate mineral deposition, the same cultures 
were stained with 2.5% wt/vol silver nitrate solution (von Kossa staining) 
for 1 h with exposure to light. Images of rat calvarial cell cultures were 
captured using a microscope (SMZ1500; Nikon) with Plan APO objective 
(0.1 NA) attached to a charge-coupled device camera (CoolSNAP; Roper 
Scientiﬁ  c). Mineralized and ALP-positive areas were quantiﬁ  ed from four 
ﬁ  elds per well. Images of murine calvarial cell cultures were captured using 
a scanner (Perfection 1650; Epson). Mineralized and ALP-positive areas 
were quantiﬁ  ed from the entire well. Sizes of acquisition ﬁ  elds and color 
balance were standardized and 2D images were analyzed using Image 
Master software (Photon Technology International). 
  RT-PCR analyses 
  For real-time RT-PCR analyses, total RNA was isolated from differentiated 
calvarial cell cultures at 7-d intervals using TRIZOL reagent and the RNeasy 
Mini kit (QIAGEN). Primer and probe sequences for genes encoding 
Runx2 (  Runx2  ), osterix (  Sp7  ), bone sialoprotein (  Ibsp  ), osteocalcin 
(  Bglap1  ), Sox9 (  Sox9  ), and collagen type II     1 (  Col2a1  ) were designed 
using PrimerDesigner software (Applied Biosystems; Table S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200708037/DC1). Primers 
and probes for P2X7 (  P2rx7  ), PPAR     (  Pparg  ), lipoprotein lipase (  Lpl  ), and 
COX-2 (  Ptgs2  ) were purchased from Applied Biosystems (Gene Expression 
Assay). Real-time RT-PCR was performed using the ABI Prism 7900 HT 
Sequence Detector (PerkinElmer) with 15-  μ  l ﬁ  nal reaction volumes, which 
contained a 25-ng RNA sample, TaqMan One-step Master Mix kit 
(Applied Biosystems), and gene-speciﬁ  c target primers and probes (FAM 
dye). Internal control reaction was performed using 18S ribosomal RNA 
primers and probes (VIC dye). Reverse transcription was performed at 48  °  C 
for 30 min. Ampliﬁ  cation was performed for 40 cycles with an annealing 
temperature of 60  °  C. All samples were ampliﬁ  ed in three parallel reactions. 
Data from serial dilution of total RNA were used to calculate relative quan-
tities of transcripts of interest and 18S ribosomal RNA. Transcript levels 
were normalized to levels of 18S ribosomal RNA in the same samples. 
  For conventional RT-PCR analysis of   P2rx7   expression, total RNA was 
extracted from undifferentiated cultures of cells isolated from rat calvariae and 
long bones, as well as the UMR-106 osteoblast-like cell line (negative control). 
RT-PCR was performed as described previously (  Dixon et al., 2004  ). Images of 
gels were acquired using an AlphaImager 2200 (Alpha Innotech Corporation) 
with a zoom lens (Computar TV; 1.2 NA; CBC (AMERICA) Corporation). 
  In summary, we propose that the P2X7-LPA axis, together 
with eicosanoid signaling, promotes osteogenesis. It is well es-
tablished that release of the endogenous P2X7 agonist ATP is 
stimulated by fl  uid shear and mechanical deformation of cells 
(  Romanello et al., 2001  ;   Genetos et al., 2005  ;   Riddle et al., 
2007  ). Thus, the P2X7-LPA axis likely plays a critical role in 
skeletal remodeling and mechanotransduction. 
  Materials and methods 
  Materials 
      -MEM, heat-inactivated FBS, antibiotic solution (10,000 units/ml penicil-
lin, 10,000   μ  g/ml streptomycin, and 25   μ  g/ml amphotericin B), PBS, 
TRIZOL reagent, SYTO-13, propidium iodide, HOECHST 33342, ﬂ  uo-4-
AM, and Pluronic F127 were obtained from Invitrogen. Nucleotides, colla-
genase type II, naphthol AS-MX phosphate, Fast Red B salt, ibuprofen, and 
LPA (1-oleoyl-  sn  -glycero-3-phosphate) were purchased from Sigma-Aldrich. 
1-Butanol, NS-398, and ethidium bromide were obtained from EMD.   tert  -
Butanol was obtained from Thermo Fisher Scientiﬁ   c. BEL was obtained 
from BIOMOL International, L.P. [U- 
14  C]Glycerol was obtained from Perkin-
Elmer. VPC-32183 and reference membrane lipids, including 16:0-18:1 
phosphatidylcholine, 16:0 lysophosphatidylcholine, 16:0-18:1 phospha-
tidic acid, 16:0 LPA, 16:0-18:1 phosphatidylethanolamine, 16:0-18:1 
phosphatidylglycerol, and 16:0 lysophosphatidylglycerol were obtained 
from Avanti Polar Lipids, Inc. Stock solutions of LPA and VPC-32183 were 
prepared in 3% BSA and aliquots were stored at     20  °  C. Nominally diva-
lent cation-free buffer contained the following: 140 mM NaCl, 5 mM KCl, 
20 mM Na-Hepes, and 10 mM glucose, pH 7.35   ±   0.02, 290   ±   5 mos-
mol/L. For short-term experiments, we used BzATP in buffer at 300   μ  M, a 
concentration which we have previously shown to induce maximal bleb-
bing activity in calvarial osteoblasts (  Panupinthu et al., 2007  ). For long-
term experiments, we used 100   μ  M BzATP in medium (~EC  50  ) to minimize 
possible nonspeciﬁ  c effects. 
  Animals 
  The   P2rx7   
    /      mouse, generated as described previously (  Solle et al., 
2001  ), was obtained from Pﬁ  zer. Both wild-type and   P2rx7   
    /      mice were 
maintained in a mixed genetic background (129/Ola   ×   C57BL/6   ×   
DBA/2) by crossbreeding of   P2rx7 
+/        mice. Genotypes were conﬁ  rmed 
using PCR. Sprague-Dawley rats were purchased from Charles River Labo-
ratories. These studies were approved by the Council on Animal Care at 
the University of Western Ontario. 
  Microcomputed tomography 
  Male and female wild-type and   P2rx7 
    /        mice were killed at 9 mo of age. 
Skin and viscera were removed and specimens ﬁ  xed in 10% formalin solu-
tion. Skulls together with synthetic bone (SB3) for calibration were imaged 
using a scanner (eXplore Locus MicroCT; GE Healthcare). Each skull was 
exposed to the x-ray source with a potential of 80 kV and a current of 0.45 
mA at a rate of three frames per 2 s for each angle. X-ray images were ac-
quired at an angular increment of 0.5  °   and a 360  °   rotation. Data were 
obtained with isotropic spatial resolution of 40   μ  m and reconstructed using 
Feldkamp  ’  s algorithm. Calvarial thickness and cross sectional area of the 
sagittal suture were analyzed using MicroView software (GE Healthcare). 
  In situ pore formation assay and confocal microscopy 
  Calvariae were excised from newborn wild-type and   P2rx7 
    /        mice. Each 
parietal bone was trimmed to obtain an     3   ×   3-mm sample. At time 0, 
samples were incubated at 37  °  C in nominally divalent cation-free buffer. 
At 10 min, BzATP or its vehicle was added. At 20 min, 5   μ  M SYTO-13 and 
20   μ  g/ml ethidium bromide were added to stain nuclei and reveal pore 
formation, respectively. At 22 min, samples were washed and images ac-
quired by confocal microscopy (LSM 510; Carl Zeiss, Inc.) using a Plan-
Apochromat objective (25  ×  ; 0.8 NA; Carl Zeiss, Inc.). We used 488-nm 
Ar 
+   ion laser excitation with a 500  –  530-nm band-pass emission ﬁ  lter for 
SYTO-13 and 543-nm HeNe laser excitation with a 560-nm long-pass 
emission ﬁ  lter for ethidium bromide. Images were collected and analyzed 
using LSM 510 software (Carl Zeiss, Inc.). 
  Osteoblast isolation and differentiation 
  Calvarial cells were isolated from 1-d-old rats and 5  –  7-d-old mice using 
sequential collagenase digestion, as previously described (  Bellows and 
Aubin, 1989  ) with modiﬁ   cations. Because larger yields of cells were JCB • VOLUME 181 • NUMBER 5 • 2008  870 
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  DNA assay 
  To label DNA, osteoblasts were loaded with 5   μ  g/ml HOECHST 33342 
for 30 min in culture medium at 37  °  C. Cells were trypsinized and ﬂ  uor-
escence intensity of samples from each well was measured using a ﬂ  uo  rimeter 
(RF-M2004; Photon Technology International) with excitation at 350 nm 
and emission at 450 nm. 
  Extraction of lipids and thin layer chromatography 
  Calvarial cells were isolated from newborn rats or mice (wild type and 
  P2rx7 
    /       ) and labeled with 1   μ  Ci/ml [ 
14  C]glycerol in serum-free     -MEM 
for 18 h. Medium containing unincorporated radiolabel was then replaced 
with nominally divalent cation-free buffer at 37  °  C containing inhibitors or 
vehicle. After 10 min, BzATP or its vehicle (control) was added. After a fur-
ther 20 min, buffer was removed and lipids were extracted from the cell 
layer (  Bligh and Dyer, 1959  ). Extracts were dried under a stream of N  2   
and dissolved in chloroform together with the reference membrane lipids. 
Silica gel plates (LK4D; Whatman) were sprayed with a solution of 0.05 M 
magnesium acetate and 0.35 M oxalic acid. After plates were dried, sam-
ples were loaded and separated by thin layer chromatography using the 
following solvent system (by volume): 34:30:35:6.5 ethanol/chloroform/
triethylamine/water. After chromatography, plates were sprayed with 0.1 mM 
primulin in 80% acetone and examined under UV light. Regions of silica 
gel deﬁ  ned by reference lipids were collected and radioactivity was quan-
tiﬁ  ed by liquid scintillation counting. Images of reference lipids were 
acquired using Polaroid MP-4+ camera system (4.5 NA; Polaroid) with 
UV illumination. 
  Fluorescence measurement of [Ca 
2+  ]  i   
  Undifferentiated calvarial cells were plated on 35-mm glass bottom cul-
ture dishes (MatTek Corporation) at a density of 3   ×   10 
4   cells/cm 
2   for 
24 h. Cells were loaded by incubation with 2.5   μ  M ﬂ  uo-4-AM and 0.1% 
Pluronic F127 in serum-free     -MEM for 30 min at 37  °  C. Cultures then 
were washed with serum-free medium, incubated with VPC-32183 or ve-
hicle, and examined by confocal microscopy at room temperature using 
a Plan-Apochromat 40  ×   objective (1.2 NA; Carl Zeiss, Inc.) with 488-nm 
Ar 
+   ion laser excitation. Emission wavelength was gathered using a 
500  –  530-nm band-pass ﬁ  lter. Fluorescence intensity was analyzed using 
LSM 510 software. 
  PGE  2   assay 
  Rat calvarial cells were incubated in serum-free     -MEM at 37  °  C for 18 h. 
Medium was then replaced with nominally divalent cation-free buffer con-
taining inhibitors or vehicle for 10 min at 37  °  C. BzATP or its vehicle (con-
trol) was then added. After a further 5 min, buffer was collected and PGE  2   
levels were measured using PGE  2   Express Enzyme Immunoassay kit (Cay-
man Chemical). 
  Statistical analyses 
  Data are shown as means   ±   SEM. Differences between two groups were 
assessed using   t   tests. Differences among three or more groups were evalu-
ated by one-way analysis of variance followed by a Tukey multiple com-
parisons test, or two-way analysis of variance followed by a Bonferroni 
multiple comparisons test. Differences were accepted as statistically signiﬁ  -
cant at P   <   0.05. 
  Online supplemental material 
  Fig. S1 shows that osteoblasts from both calvariae and long bones express 
  P2rx7   transcripts and that P2X7 receptors on long bone cells are func-
tional. Fig. S2 shows that BzATP does not affect phosphatidylethanolamine 
levels in rat calvarial cell cultures. Fig. S3 shows that VPC-32183 and NS-
398 do not affect cell numbers in rat calvarial cell cultures during differen-
tiation. Table S1 is a list of the custom-designed primer and probe sequences 
used for real-time RT-PCR analyses. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200708037/DC1. 
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